Senti Biosciences CFO Deborah Knobelman receives $1.1M in 2022
Senti Biosciences reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Senti Biosciences reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Senti Biosciences received on average a compensation package of $918K, a 96% decrease compared to previous year.
Average pay of disclosed executives at Senti Biosciences
Deborah Knobelman, Chief Financial Officer, received $1.1M in total. 39% of Knobelman's compensation, or $428K, was in option awards. Knobelman also received $170K in non-equity incentive plan, $425K in salary, $75K in stock awards, as well as $5.2K in other compensation.
Kanya Rajangam, Chief Medical Officer, received a compensation package of $841K. 49% of the compensation package, or $413K, was in option awards.
Timothy Lu, M.D.,Ph.D, Chief Executive Officer, earned $811K in 2022, a 97% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2023.